Breaking News

Gentronix Expands Tox Screening Services

Adds apoptosis to testing portfolio

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Gentronix has expanded its service testing portfolio with the launch of Apoptosis Suite, a set of in vitro assays to detect apoptosis induction. The suite can be utilized to provide mechanistic information regarding the cytotoxicity profile within a novel chemical series. Apoptosis, or programmed cell death, is used by the body to remove unwanted, damaged or senescent cells from tissues.   New compounds are subject to a wide range of cytotoxicity hazard assessments. One such measure is the induc...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters